CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 11 - 20 of 880
Study Number Lead Group Study Title CIRB Study Status
EAQ191 ECOG-ACRIN Cancer Therapy Risk-Reduction with Intensive Systolic BP Management (CARISMA) – a Phase II Study Cancer Prevention and Control CIRB Available to Open
EA4181 ECOG-ACRIN A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab and High Dose Cytarabine (BR/CR) 2.) Bendamustine, Rituximab, High Dose Cytarabine and Acalabrutinib (BR/CR-A), and 3.) Bendamustine, Rituximab and Acalabrutinib (BR-A) in Patients ≤ 70 years old with Untreated Mantle Cell Lymphoma Adult CIRB - Late Phase Emphasis Available to Open
GOG-0262 GOG GOG-0262: A Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel In Combination With Carboplatin With Or Without Concurrent and Consolidation Bevacizumab (NSC #704865; IND #113912) in the Treatment of Primary Stage II; III OR IV Epithelial Ovarian; Peritoneal or Fallopian Tube Cancer and ACRIN 6695: Perfusion CT Imaging To Evaluate Treatment Response in Patients Participating in GOG-0262 Adult CIRB - Late Phase Emphasis Available to Open
10096 ETCTN A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE) Adult CIRB - Early Phase Emphasis Available to Open
AEWS1031 COG A Phase III Randomized Trial of Adding Vincristine-topotecan-cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma: A Groupwide Phase III Study Pediatric CIRB Available to Open
S1314 SWOG A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized; Muscle-Invasive Bladder Cancer Adult CIRB - Late Phase Emphasis Available to Open
A031702 Alliance A Phase II Study of Ipilimumab, Cabozantinib, and NIvolumab in Rare Genitourinary Cancers (ICONIC) Adult CIRB - Late Phase Emphasis Available to Open
9767 ETCTN An Open Label; Multicenter; Single arm Phase II study to evaluate the Activity and Tolerability of the novel mTOR Inhibitor; MLN0128 (TAK-228); in patients with Locally Advanced or Metastatic Transitional Cell Carcinoma of the urothelial tract whose tumors harbor a TSC1 and/or a TSC2 mutation Adult CIRB - Early Phase Emphasis Available to Open
APEC1621-MASTER COG NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Study Pediatric CIRB Available to Open
EA1151 ECOG-ACRIN Tomosynthesis Mammographic Imaging Screening Trial (TMIST) Cancer Prevention and Control CIRB Available to Open
Displaying 11 - 20 of 880